Skip to main content

European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases

Objective

The overall objective of this 5-year project is to build a multinational, adaptive European COVID-19 and emerging infectious diseases trial network, based on existing initiatives, experience and expertise, allowing European expansion of DisCoVeRy (WP1) and the establishment of a COVID19 adaptive platform trial (WP2). The DisCoVeRy trial, designed as a multi-arm adaptive repurposing trial, initiated in France, has the potential to expand to many other European countries with appropriate support in terms of multinational funding and trial management capacity. This will complete the evaluation of repurposed drugs, while building a European clinical trial network which, together with other European networks such as the Solidarity trial, will design and run a new European platform trial. EU-RESPONSE will swiftly generate robust evidence for drug repurposing or registration, through a modular trial framework allowing most European hospitals to participate at their preferred level of commitment, thus building a network of investigation sites within European and associated countries. Cooperation with other European platforms, in particular the RECOVER consortium platform will be achieved through a joint coordination mechanism aligned with European and national policies (WP3), ensuring a coordinated strategy for the European COVID-19 Adaptive Platform Trials, their complementarity in providing access for requests for a new domain or arm, their synergy and cross-fertilization through the development of a common toolbox for the development and the management of Adaptive Platform Trials. Joining forces in Europe and with international partners, it will contribute to the global clinical trial capacity for urgently meeting the expectations of society and developers. It will also boost multinational cooperation in Europe and promote the establishment of adaptive platform trials in other diseases, and will have a major impact on epidemic control.

Field of science

  • /medical and health sciences/health sciences/infectious disease
  • /medical and health sciences/health sciences/epidemiology/pandemics

Call for proposal

H2020-IBA-SC1-CORONAVIRUS-2020-3
See other projects for this call

Funding Scheme

RIA - Research and Innovation action

Coordinator

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Address
Rue De Tolbiac 101
75654 Paris
France
Activity type
Research Organisations
EU contribution
€ 11 638 033

Participants (20)

ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK
France
EU contribution
€ 1 175 498,50
Address
5 Rue Watt
75013 Paris
Activity type
Research Organisations
FOLKEHELSEINSTITUTTET
Norway
EU contribution
€ 257 000
Address
Lovisenberggata 8
0456 Oslo
Activity type
Research Organisations
OSLO UNIVERSITETSSYKEHUS HF
Norway
EU contribution
€ 814 243,75
Address
Kirkeveien 166 Tarnbygget
0450 Oslo
Activity type
Higher or Secondary Education Establishments
UNIVERSITA DEGLI STUDI DI VERONA
Italy
EU contribution
€ 307 047,50
Address
Via Dell Artigliere 8
37129 Verona
Activity type
Higher or Secondary Education Establishments
CENTRO HOSPITALAR DE SAO JOAO EPE
Portugal
EU contribution
€ 30 166
Address
Alamesa Do Professor Hernani Monteiro
4200 319 Porto
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
INSERM TRANSFERT SA
France
EU contribution
€ 277 500
Address
Rue Watt 7
75013 Paris
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
UNIVERZITA PAVLA JOZEFA SAFARIKA V KOSICIACH
Slovakia
EU contribution
€ 17 125
Address
Srobarova 2
04180 Kosice
Activity type
Higher or Secondary Education Establishments
UNIVERSITE LIBRE DE BRUXELLES
Belgium
EU contribution
€ 17 125
Address
Avenue Franklin Roosevelt 50
1050 Bruxelles
Activity type
Higher or Secondary Education Establishments
SZEGEDI TUDOMANYEGYETEM
Hungary
EU contribution
€ 17 125
Address
Dugonics Ter 13
6720 Szeged
Activity type
Higher or Secondary Education Establishments
UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK
Ireland
EU contribution
€ 12 250
Address
Western Road
T12 YN60 Cork
Activity type
Higher or Secondary Education Establishments
SWISS CLINICAL TRIAL ORGANISATION
Switzerland
EU contribution
€ 42 625
Address
Effingerstrasse 35
3008 Bern
Activity type
Other
HACETTEPE UNIVERSITESI
Turkey
EU contribution
€ 17 125
Address
Hacettepe Universitesi Beytepe Kampusu Rektorluk Binasi
06800 Cankaya Ankara
Activity type
Higher or Secondary Education Establishments
CENTRE HOSPITALIER DE LUXEMBOURG
Luxembourg
EU contribution
€ 17 125
Address
Rue Nicolas Ernest Barble 4
1210 Luxembourg
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
ARBEITSGEMEINSCHAFT MEDIKAMENTOSE TUMORTHERAPIE GEMEINNUTZIGE GMBH
Austria
EU contribution
€ 17 125
Address
Gentzgasse 60/21
1180 Wien
Activity type
Research Organisations
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
France
EU contribution
€ 789 836,25
Address
3 Avenue Victoria
75000 Paris
Activity type
Research Organisations
HOSPICES CIVILS DE LYON
France
EU contribution
€ 204 000
Address
Quai Des Celestins 3
69002 Lyon
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SERVICIO MADRILENO DE SALUD
Spain
EU contribution
€ 17 125
Address
Plaza Carlos Trias Bertran 7
28020 Madrid
Activity type
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON
Greece
EU contribution
€ 17 125
Address
6 Christou Lada Str
10561 Athina
Activity type
Higher or Secondary Education Establishments
UNIVERSYTET MEDYCZNY W LODZI.
Poland
EU contribution
€ 17 125
Address
Al. Kosciuszki, 4
90419 Lodz
Activity type
Higher or Secondary Education Establishments
UNIVERZITA KARLOVA
Czechia
EU contribution
€ 17 125
Address
Ovocny Trh 560/5
116 36 Praha 1
Activity type
Higher or Secondary Education Establishments